Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

BNTCBNTC
5 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in BENITEC BIOPHARMA INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 70,851 shares of BNTC (BENITEC BIOPHARMA INC), worth $947,986 as of 2026-Q2. The position was increased (+15.4% shares). BNTC represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$947,986

Current Shares

70,851

Total Value Change

+$418,280

Total Shares Change

+25,577

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
70,851
+15.4%
$947,9860.0%$13.38
29
2026-Q1
Increased
61,411
+35.6%
$654,0270.0%$10.46
32
2025-Q4
Unchanged
45,274
0.0%
$609,8410.0%$13.93
0
2025-Q3
Unchanged
45,274
0.0%
$635,1940.0%$13.99
0
2025-Q2
New
45,274
-
$529,7060.0%$11.35
34

Other major holders of BNTC: Janus Henderson Group Ltd., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used